Exeliom Biosciences
Benjamin Hadida, Co-founder, CEO
Country: France | Funding: €22.3M (+)
Website: https://www.exeliombio.com/
Exeliom Biosciences develops a bacterial treatment for inflammatory bowel diseases. It's intended to rebalance the gut microbiome through the delivery of Faecalibacterium prausnitzii, one of the most abundant species of bacteria in the gut.
Website: https://www.exeliombio.com/
Exeliom Biosciences develops a bacterial treatment for inflammatory bowel diseases. It's intended to rebalance the gut microbiome through the delivery of Faecalibacterium prausnitzii, one of the most abundant species of bacteria in the gut.
